Abstract
Although the genetic contribution to schizophrenia is substantial, positive findings in whole-genome linkage scans have not been consistently replicated. We analyzed gene expression in various rat conditions to identify novel candidate genes for schizophrenia. Suppression subtraction hybridization (SSH), with polyA mRNA from temporal and frontal cortex of rats, was used to identify differentially expressed genes. Expression of mRNA was compared between adult Lewis and Fischer 344 (F344) rats, adult and postnatal day 6 (d6) F344, and adult F344 treated with haloperidol or control vehicle. These groups were chosen because each highlights a particular aspect of schizophrenia: differences in strain vulnerability to behavioral analogs of psychosis; factors that may relate to disease onset in relation to CNS development; and improvement of symptoms by haloperidol. The 14-3-3 gene family, as represented by 14-3-3γ and 14-3-3ζ isoforms in the SSH study, and SNAP-25 were among the candidate genes. Genetic association between schizophrenia and the 14-3-3η gene, positioned close to a genomic locus implicated in schizophrenia, and SNAP-25 genes was analyzed in 168 schizophrenia probands and their families. These findings address three different genes in the 14-3-3 family. We find a significant association with schizophrenia for two polymorphisms in the 14-3-3η gene: a 7 bp variable number of tandem repeats in the 5′ noncoding region (P=0.036, 1 df), and a 3′ untranslated region SNP (753G/A) that is an RFLP visualized with Ava II (P=0.028). There was no significant genetic association with SNAP-25. The candidate genes identified may be of functional importance in the etiology, pathophysiology or treatment response of schizophrenia or psychotic symptoms. This is to our knowledge the first report of a significant association between the 14-3-3η-chain gene and schizophrenia in a family-based sample, strengthening prior association reports in case–control studies and microarray gene expression studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jablensky A . Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000; 250: 274–285.
Sartorius N, Jablensky A, Korten A . Early manifestations and first contact incidence of schizophrenia in different cultures: a preliminary report on the inital evaluation phase of the WHO collaborative study on determinants of outcome of severe mental disorders. Psychol Med 1986; 16: 909–928.
Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS . Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21–q22. Science 2000; 288: 678–682.
Riley BP, McGuffin P . Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97: 23–44.
Lander E, Kruglyak L . Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241–247.
Risch N . Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990; 46: 229–241.
Risch N . Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990; 46: 222–228.
Lipska BK, Jaskiw GE, Weinberger DR . Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993; 9: 67–75.
Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR . Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 1995; 122: 35–43.
Lipska BK, Jaskiw GE, Braun AR, Weinberger DR . Profrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviours in the rat. Biol Psychiatry 1995; 38: 255–262.
Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA . Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in rats. Psychopharmacology 1995; 122: 27–34.
Chambers RA, Moore J, McEvoy JP, Levin ED . Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 1996; 15: 587–594.
Lillrank SM, Lipska BK, Kolachana BS, Weinberger DR . Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage. J Neural Transm 1999; 106: 183–196.
Lipska BK, Weinberger DR . Genetic variation in vulnerability to the behavioural effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci 1995; 92: 8906–8910.
Lipska BK, Weinberger DR . To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000; 23: 223–239.
Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122(Part 4): 593–624.
Weinberger D . Neurodevelopmental perspectives on schizophrenia. In: Bloom F, Kupfer D (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press Ltd: New York, 1995, pp 1171–1183.
Diatchenko L et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes or libraries. Proc Natl Acad Sci 1996; 93: 6025–6030.
DSM-IV TFo. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994.
Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849–859; discussion 863-4.
Lahiri DK, Nurnberger Jr JI . A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
Bell R, Munro J, Russ C, Powell JF, Bruinvels A, Kerwin RW et al. Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia. Am J Med Genet 2000; 96: 736–743.
Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M et al. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 2000; 5: 405–409.
Spielman RS, Ewens WJ . A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998; 62: 450–458.
Laird NM, Horvath S, Xu X . Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1): S36–S42.
Hess EJ, Collins KA, Wilson MC . Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci 1996; 16: 3104–3111.
Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 1998; 8: 261–268.
Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S et al. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. Am J Med Genet 1994; 54: 44–50.
Murphy KC, Jones LA, Owen MJ . High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940–945.
Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood 3rd WH, Donovan DM et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641–650.
Toyooka K, Muratake T, Tanaka T, Igarashi S, Watanabe H, Takeuchi H et al. 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet 1999; 88: 164–167.
Risch N . Searching for genes in complex diseases: lessons from systemic lupus erythematosus. J Clin Invest 2000; 105: 1503–1506.
Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 1995; 29: 217–224.
Kung L, Roberts RC . Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 1999; 31: 67–75.
Whatley SA, Curti D, Marchbanks RM . Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res 1996; 21: 995–1004.
Whatley SA, Curti D, Das Gupta F, Ferrier IN, Jones S, Taylor C et al. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol Psychiatry 1998; 3: 227–237.
Prince JA, Yassin MS, Oreland L . Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine. Neuropharmacology 1997; 36: 1665–1678.
Ferre S . Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia. Psychopharmacology (Berl) 1997; 133: 107–120.
Dixon DA, Fenix LA, Kim DM, Raffa RB . Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Ann Pharmacother 1999; 33: 480–488.
Deckert J, Nothen MM, Bryant SP, Schuffenhauer S, Schofield PR, Spurr NK et al. Mapping of the human adenosine A2a receptor gene: relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region. Hum Genet 1997; 99: 326–328.
Schwab SG, Wildenauer DB . Chromosome 22 workshop report. Am J Med Genet 1999; 88: 276–278.
Wilson MC, Mehta PP, Hess EJ . SNAP-25, enSNAREd in neurotransmission and regulation of behaviour. Biochem Soc Trans 1996; 24: 670–676.
Jakob H, Beckmann H . Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med 1989; 82: 466–469.
Thompson PM, Sower AC, Perrone-Bizzozero NI . Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 1998; 43: 239–243.
Maglott DR, Feldblyum TV, Durkin AS, Nierman WC . Radiation hybrid mapping of SNAP, PCSK2, and THBD (human chromosome 20p). Mamm Genome 1996; 7: 400–401.
Gejman PV . Chromosomes 19 and 20 report. Am J Med Genet 1999; 88: 271.
Thomas EA, Danielson PE, Nelson PA, Pribyl TM, Hilbush BS, Hasel KW et al. Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J Neurochem 2001; 76: 789–796.
Fu H, Subramanian RR, Masters SC . 14-3-3 proteins: structure function and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617–647.
van Hemert MJ, Steensma HY, van Heusden GP . 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 2001; 23: 936–946.
Muratake T, Hayashi S, Ichikawa T, Kumanishi T, Ichimura Y, Kuwano R et al. Structural organization and chromosomal assignment of the human 14-3-3 eta chain gene (YWHAH). Genomics 1996; 36: 63–69.
Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 1994; 54: 36–43.
Coon H, Jensen S, Holik J, Hoff M, Hoff M, Myles-Worsley M et al. Genomic scan for genes predisposing to schizophrenia. Am J Med Genet 1994; 54: 59–71.
Gill M, Vallada H, Collier D, Sham P, Holmans P, Murray R et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996; 67: 40–45.
Hovatta I, Lichtermann D, Juvonen H, Suvisaari J, Terwilliger JD, Arajarvi R et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol Psychiatry 1998; 3: 452–457.
Kalsi G, Brynjolfsson J, Butler R, Sherrington R, Curtis D, Sigmundsson T et al. Linkage analysis of chromosome 22q12–13 in a United Kingdom/Icelandic sample of 23 multiplex schizophrenia families. Am J Med Genet 1995; 60: 298–301.
Parsian A, Suarez BK, Isenberg K, Hampe CL, Fisher L, Chakraverty S et al. No evidence for a schizophrenia susceptibility gene in the vicinity of IL2RB on chromosome 22. Am J Med Genet 1997; 74: 361–364.
Riley B, Mogudi-Carter M, Jenkins T, Williamson R . No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families. Am J Med Genet 1996; 67: 515–522.
Amati F, Conti E, Novelli A, Bengala M, Diglio MC, Marino B et al. Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet 1999; 7: 903–909.
Acknowledgements
We acknowledge the support of the Canadian Institutes for Health Research, the National Institute for Mental Health, NARSAD, the Ontario Mental Health Foundation, the Canadian Psychiatric Research Foundation, and the Ontario Ministry of Health in funding this research. Dr Van Tol is supported by the Canadian Research Chair Program.
Thanks are due to Drs Barbara K Lipska and Daniel R Weinberger at NIMH for their helpful advice during this project. We also thank Tascha Cate, Jane Dalton, Greg Wong, Lisa Lee, Helena Madeiros, Celia Carvalho, Tersesa Shandrel, Camille Della Torre, Maria Soares, and Amy Bauer for their help in recruiting and interviewing clinical subjects.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wong, A., Macciardi, F., Klempan, T. et al. Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3η gene. Mol Psychiatry 8, 156–166 (2003). https://doi.org/10.1038/sj.mp.4001237
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001237
Keywords
This article is cited by
-
Dysregulation of peripheral expression of the YWHA genes during conversion to psychosis
Scientific Reports (2020)
-
Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia
Journal of Molecular Neuroscience (2018)
-
Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia
Scientific Reports (2016)
-
Loss of function of Ywhah in mice induces deafness and cochlear outer hair cells' degeneration
Cell Death Discovery (2016)
-
Rapid antidepressants stimulate the decoupling of GABAB receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η
Molecular Psychiatry (2015)